Open Angle Glaucoma
160
7
15
101
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
38 trials with published results (24%)
Research Maturity
101 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.5%
12 terminated out of 160 trials
89.4%
+2.8% vs benchmark
28%
44 trials in Phase 3/4
38%
38 of 101 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 101 completed trials
Clinical Trials (160)
Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes
Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery
STAR-LIFE: a Post-market Registry on MINIject
MINIject Global Long-Term Follow-up Study
Topical Insulin for Glaucoma (TING2)
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree
Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma
Next Generation Rocklatan
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Swedish Microinvasive Glaucoma Surgery Study (SMIGS)
Real World Evidence of Xen45 Gel Implant in Pseudoexfoliation Glaucoma